Your session is about to expire
← Back to Search
HIIT Exercise for Endometrial Cancer
Study Summary
This trial is testing whether high-intensity interval training (HIIT) can help fight endometrial cancer.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- Your body mass index (BMI) is between 30 and 50, which means you may be overweight or have obesity.I agree to visit the lab for baseline testing within 2 days if it can't be done the same day as my standard of care visit.I have access to email.I agree to follow-up visits 2 weeks after surgery, with a 2-week flexibility.I have endometrial cancer and am scheduled for a hysterectomy and staging.I have severe hearing or speech impairments.You have a serious mental health condition.You currently have a mental illness called psychosis or you are dealing with substance abuse problems that are not under control.I cannot speak English.I have not been hospitalized for stroke, heart attack, or heart failure, nor had surgery for blocked arteries in the last 3 months.My cancer is a type of endometrial cancer called endometrioid.I have severe dementia or significant memory loss.I use insulin to manage my diabetes.I am between 40 and 75 years old.My cancer is believed to be in the early stage and confined to my uterus.I have a condition that limits my physical activity.You engage in physical activity for at least 150 minutes per week, following the guidelines set by the American College of Sports Medicine.You are currently doing high-intensity interval training (HIIT) workouts.
- Group 1: HIIT exercise
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this research endeavor restricted to individuals below the age of fifty-five?
"Patients aged 18 to 75 are eligible for this medical trial. For those participants younger than 18, there are a total of 18 trials available while 280 can be found for patients over 65 years old."
What is the maximum number of participants being accepted into this research?
"Indeed, clinicaltrials.gov data confirms that there is an ongoing search for potential participants in this trial which was initially listed on May 20th 2019 and has been most recently updated on June 21st 2022. Altogether, twenty patients are required to be recruited from a solitary medical centre."
Who is the optimal subject for this medical investigation?
"Men and women aged between 18 to 75 who have been diagnosed with endometrial neoplasms are eligible for the study. The research team is seeking around 20 volunteers in total."
Are there any open slots available in this investigation for participants?
"The clinical trial is accepting patients, as the data hosted on clinicaltrials.gov attests to this; the initial post was made on May 20th 2019 and last modified June 21st 2022."
Share this study with friends
Copy Link
Messenger